Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 5
1964 4
1965 1
1966 4
1967 6
1968 6
1969 14
1970 17
1971 16
1972 15
1973 22
1974 21
1975 15
1976 19
1977 25
1978 23
1979 28
1980 26
1981 26
1982 21
1983 36
1984 83
1985 52
1986 43
1987 66
1988 117
1989 147
1990 163
1991 135
1992 199
1993 154
1994 148
1995 169
1996 156
1997 191
1998 155
1999 175
2000 220
2001 183
2002 233
2003 228
2004 205
2005 246
2006 224
2007 250
2008 266
2009 219
2010 239
2011 257
2012 291
2013 321
2014 317
2015 376
2016 359
2017 322
2018 369
2019 271
2020 349
2021 357
2022 383
2023 369
2024 146

Text availability

Article attribute

Article type

Publication date

Search Results

8,751 results

Results by year

Filters applied: . Clear all
Page 1
Bladder Cancer: A Review.
Lenis AT, Lec PM, Chamie K, Mshs MD. Lenis AT, et al. JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598. JAMA. 2020. PMID: 33201207 Review.
Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality. OBSERVATIONS: Advanced age, male sex, and cigaret …
Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive su …
Bladder cancer.
Dyrskjøt L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Dyrskjøt L, et al. Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9. Nat Rev Dis Primers. 2023. PMID: 37884563 Free article. Review.
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways depending on whether the disease is non-muscle invasive or muscle invasive. ...
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder cancer has distinct molecular …
Application of nanotechnology in the diagnosis and treatment of bladder cancer.
Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Xu Y, et al. J Nanobiotechnology. 2021 Nov 27;19(1):393. doi: 10.1186/s12951-021-01104-y. J Nanobiotechnology. 2021. PMID: 34838048 Free PMC article. Review.
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder cancer diagnosis. Nanoparticles targeting bladder cancers can facilitate to distinguish the normal and abnormal bladder tissues d …
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder can …
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
Soorojebally Y, Neuzillet Y, Roumiguié M, Lamy PJ, Allory Y, Descotes F, Ferlicot S, Kassab-Chahmi D, Oudard S, Rébillard X, Roy C, Lebret T, Rouprêt M, Audenet F. Soorojebally Y, et al. World J Urol. 2023 Feb;41(2):345-359. doi: 10.1007/s00345-022-04253-3. Epub 2023 Jan 2. World J Urol. 2023. PMID: 36592175 Review.
Current research focuses on diagnostic biomarkers that could improve bladder cancer detection and follow-up by discriminating patients at risk of aggressive cancer who need confirmatory TURBT (Transurethral Resection of Bladder Tumour) from patients at no ris …
Current research focuses on diagnostic biomarkers that could improve bladder cancer detection and follow-up by discriminating patient …
The mechanism of action of BCG therapy for bladder cancer--a current perspective.
Redelman-Sidi G, Glickman MS, Bochner BH. Redelman-Sidi G, et al. Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4. Nat Rev Urol. 2014. PMID: 24492433 Review.
Bacillus Calmette-Guerin (BCG) has been used to treat non-muscle-invasive bladder cancer for more than 30 years. It is one of the most successful biotherapies for cancer in use. ...Immune system cell subsets that have potential roles in BCG therapy include CD4(+) and CD8(+ …
Bacillus Calmette-Guerin (BCG) has been used to treat non-muscle-invasive bladder cancer for more than 30 years. It is one of the mos …
Urinary markers for bladder cancer diagnosis: A review of current status and future challenges.
Tomiyama E, Fujita K, Hashimoto M, Uemura H, Nonomura N. Tomiyama E, et al. Int J Urol. 2024 Mar;31(3):208-219. doi: 10.1111/iju.15338. Epub 2023 Nov 15. Int J Urol. 2024. PMID: 37968825 Review.
Urine, which is in continuous contact with bladder cancer, is considered a suitable fluid for providing tumor information. Urinary cytology is the only widely used urinary marker in clinical practice; however, it has poor sensitivity for low-grade t …
Urine, which is in continuous contact with bladder cancer, is considered a suitable fluid for providing tumor information. …
Tissue-engineered urinary conduits.
Kates M, Singh A, Matsui H, Steinberg GD, Smith ND, Schoenberg MP, Bivalacqua TJ. Kates M, et al. Curr Urol Rep. 2015 Mar;16(3):8. doi: 10.1007/s11934-015-0480-3. Curr Urol Rep. 2015. PMID: 25677229 Review.
The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bla …
The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing dise …
MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging.
Takeuchi M, Sasaki S, Naiki T, Kawai N, Kohri K, Hara M, Shibamoto Y. Takeuchi M, et al. J Magn Reson Imaging. 2013 Dec;38(6):1299-309. doi: 10.1002/jmri.24227. Epub 2013 Nov 21. J Magn Reson Imaging. 2013. PMID: 24265260 Review.
Treatment decisions for bladder cancer patients are mainly based on the depth of bladder wall invasion by the tumor. In this article, we review the conventional MRI and exhibit a recently emerged diffusion-weighted imaging (DWI) of urinary bladder …
Treatment decisions for bladder cancer patients are mainly based on the depth of bladder wall invasion by the tumor. In …
Molecular classification of urothelial bladder carcinoma.
Schwarzova L, Varchulova Novakova Z, Danisovic L, Ziaran S. Schwarzova L, et al. Mol Biol Rep. 2023 Sep;50(9):7867-7877. doi: 10.1007/s11033-023-08689-7. Epub 2023 Jul 31. Mol Biol Rep. 2023. PMID: 37525073 Free PMC article. Review.
Urothelial bladder carcinoma (UC) ranks among the top ten most commonly diagnosed cancers worldwide on an annual basis. The standardized classification system for urothelial bladder tumors is the Tumor, Node, Metastasis classification, which reflects d …
Urothelial bladder carcinoma (UC) ranks among the top ten most commonly diagnosed cancers worldwide on an annual basis. The standardi …
T-type Ca2+ channels and the urinary and male genital tracts.
Fry CH, Jabr RI. Fry CH, et al. Pflugers Arch. 2014 Apr;466(4):781-9. doi: 10.1007/s00424-014-1446-x. Epub 2014 Jan 25. Pflugers Arch. 2014. PMID: 24463704 Review.
T-type Ca(2+) channels are widely expressed throughout the urinary and male genital tracts, generally alongside L-type Ca(2+) channels. ...Moreover, T-type Ca(2+) channels may have a role in the development of prostate tumours regulating the secretion of mitogens fr …
T-type Ca(2+) channels are widely expressed throughout the urinary and male genital tracts, generally alongside L-type Ca(2+) channel …
8,751 results